D
Daniel W. Chan
Researcher at Hong Kong Polytechnic University
Publications - 707
Citations - 47988
Daniel W. Chan is an academic researcher from Hong Kong Polytechnic University. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 106, co-authored 663 publications receiving 41915 citations. Previous affiliations of Daniel W. Chan include Merck & Co. & Charité.
Papers
More filters
Journal ArticleDOI
Updating risk prediction tools: A case study in prostate cancer
Donna P. Ankerst,Donna P. Ankerst,Tim Koniarski,Yuanyuan Liang,Robin J. Leach,Ziding Feng,Martin G. Sanda,Alan W. Partin,Daniel W. Chan,Jacob Kagan,Lori J. Sokoll,John T. Wei,Ian M. Thompson +12 more
TL;DR: The application of Bayes rule is reported on for updating risk prediction tools to include a set of biomarkers measured in an external study to the original study used to develop the risk prediction tool.
Journal Article
Strategies for improving safety performance of repair, maintenance, minor alteration and addition (RMAA) works
TL;DR: In this paper, the authors identify and then evaluate the various strategies for improving the safety performance of RMAA works and highlight possible ways to enhance safety of the rather under-explored RMAA sector.
Journal ArticleDOI
A structural mutation of the collagen alpha 1(I)CB7 peptide in lethal perinatal osteogenesis imperfecta.
TL;DR: Findings support the proposal that the lysine overhydroxylation resulted from a perturbation of helix propagation from the COOH to NH2 terminus of the collagen trimer caused by the structural defect in alpha 1(I)CB7.
Journal ArticleDOI
Empirical Study of the Risks and Difficulties in Implementing Guaranteed Maximum Price and Target Cost Contracts in Construction
TL;DR: In this article, the authors provide a concise review of the potential pitfalls of the guaranteed maximum price (GMP) and target cost contracting (TCC) schemes in general and identify the key risk factors and potential difficulties associated with GMP/TCC in comparison with other procurement strategies in construction in particular via an empirical survey of clients, contractors, and consultants in Hong Kong.
Journal ArticleDOI
Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer
Jin Song,Lori J. Sokoll,Jered J. Pasay,Abigail L. Rubin,Hanying Li,Dylan M. Bach,Daniel W. Chan,Zhen Zhang +7 more
TL;DR: The biomarker panels evaluated by assays with high analytical performance demonstrated potential complementary values to CA19-9, warranting additional clinical validation to determine their role in early detection of pancreatic cancer.